| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-0102(03)00195-0 |
| P698 | PubMed publication ID | 12941454 |
| P50 | author | Sheng Tian Li | Q57883041 |
| P2093 | author name string | Hideki Matsui | |
| Kazuhito Tomizawa | |||
| Masayuki Matsushita | |||
| Hai-Yan Wu | |||
| Yun-Fei Lu | |||
| Sheng-Tian Li | |||
| P2860 | cites work | Structure and physiological function of calpains | Q24530607 |
| Glutamate as a neurotransmitter in the brain: review of physiology and pathology | Q28139934 | ||
| Neurotoxicity induces cleavage of p35 to p25 by calpain | Q28145382 | ||
| Calpain inhibitors as therapeutic agents in nerve and muscle degeneration | Q33936871 | ||
| A survey of calpain inhibitors | Q34060656 | ||
| Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function | Q34296896 | ||
| Protein Therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery | Q35100895 | ||
| Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats | Q36895149 | ||
| Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake | Q40692947 | ||
| Calpain: new perspectives in molecular diversity and physiological-pathological involvement. | Q40694801 | ||
| Development and therapeutic potential of calpain inhibitors | Q41188037 | ||
| The role of the calpain-calpastatin system in thyrotropin-releasing hormone-induced selective down-regulation of a protein kinase C isozyme, nPKC epsilon, in rat pituitary GH4C1 cells | Q41281555 | ||
| A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. | Q43697222 | ||
| Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT. | Q44261564 | ||
| Role of Calpain in Spinal Cord Injury: Effects of Calpain and Free Radical Inhibitorsa | Q47671491 | ||
| Ca2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells | Q48226175 | ||
| A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death | Q71693449 | ||
| Time-Related Neuronal Changes following Middle Cerebral Artery Occlusion: Implications for Therapeutic Intervention and the Role of Calpain | Q71825468 | ||
| Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors | Q73371207 | ||
| Positively charged DNA-binding proteins cause apparent cell membrane translocation | Q77642498 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 131-135 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Neuroscience Research | Q15764280 |
| P1476 | title | Poly-arginine-fused calpastatin peptide, a living cell membrane-permeable and specific inhibitor for calpain | |
| P478 | volume | 47 |
| Q37857282 | Calpain inhibitors: a survey of compounds reported in the patent and scientific literature |
| Q35603349 | Calpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell Model |
| Q36795351 | Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives |
| Q61808474 | Computational and experimental analysis of bioactive peptide linear motifs in the integrin adhesome |
| Q33195171 | Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. |
| Q48782705 | Determination of tissue levels of a neuroprotectant drug: the cell permeable JNK inhibitor peptide |
| Q35063603 | Nanomedicine strategies for treatment of secondary spinal cord injury |
| Q33619612 | Peptide HIV-1 integrase inhibitors from HIV-1 gene products. |
| Q37812402 | Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation |
| Q34378560 | Quantum dots targeted to the assigned organelle in living cells |
| Q46404108 | Regulation of N-methyl-D-aspartate receptors by calpain in cortical neurons |
Search more.